BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18219339)

  • 1. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
    Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
    Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.
    Maloney SC; Marshall JC; Antecka E; Orellana ME; Fernandes BF; Martins C; Castiglione E; DI Cesare S; Logan P; Burnier MN
    Anticancer Res; 2009 Aug; 29(8):3059-64. PubMed ID: 19661316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of RASSF1A in uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics of liver metastases from uveal melanoma.
    Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of Mart-1 in human uveal melanoma cells.
    Wang J; Jia R; Yao Y; Cun B; Huang X; Gu P; Ge S; Fan X
    Mol Med Rep; 2011; 4(5):799-803. PubMed ID: 21667026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
    Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of RASSF1a in uveal melanoma.
    Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NBS1 expression as a prognostic marker in uveal melanoma.
    Ehlers JP; Harbour JW
    Clin Cancer Res; 2005 Mar; 11(5):1849-53. PubMed ID: 15756009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma.
    Dror R; Lederman M; Umezawa K; Barak V; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1811-6. PubMed ID: 19892878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
    Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.
    Goldberg SF; Miele ME; Hatta N; Takata M; Paquette-Straub C; Freedman LP; Welch DR
    Cancer Res; 2003 Jan; 63(2):432-40. PubMed ID: 12543799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23.
    Shirasaki F; Takata M; Hatta N; Takehara K
    Cancer Res; 2001 Oct; 61(20):7422-5. PubMed ID: 11606374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.
    Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS
    Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.